AllerVie Clinical Research
AllerVie Clinical Research is a U.S. clinical research site organization, founded in 1998 and affiliated with AllerVie Health, that conducts Phase II–IV clinical trials for pharmaceutical sponsors and CROs across 13+ allergy, asthma, and immunology indications through six clinic locations.
- Company typePrivate
- Founded1998
- HeadquartersNot specified, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What AllerVie Clinical Research does
AllerVie Clinical Research is a U.S. clinical research site organization that conducts Phase II, III, and IV clinical trials for pharmaceutical sponsors and Contract Research Organizations (CROs), specializing in asthma, allergies, and immunology. Founded in 1998 and operating as a subsidiary of AllerVie Health, the company runs 48+ active studies across six clinic locations nationwide, with new sites added on a stated quarterly cadence. Its therapeutic footprint spans 13+ indications including asthma, COPD, eczema, environmental and food allergies, GI conditions, hereditary angioedema (HAE), hives, primary immunodeficiency, nasal polyps/sinusitis, and alopecia, in both adult and pediatric populations.
The business is built on three interlocking customer segments: patients who participate in trials at no cost, referring board-certified allergists and immunologists who feed the recruitment funnel, and pharmaceutical sponsors and CROs who pay for trial execution. Revenue is generated through professional services contracts for study execution, patient recruitment, and regulatory documentation, with the company claiming high completion rates and minimal screen failures driven by rigorous pre-screening. The AllerVie Health network affiliation provides a structural advantage in patient access by supplying a continuous stream of board-certified specialists and pre-qualified patients, while research coordinators and assistants are certified by the Association of Clinical Research Professionals.
The go-to-market is dual: a sales-led B2B motion targeting sponsors and CROs for trial contracts, layered with a community-led motion targeting patients and referring physicians via website, social media (Facebook, Instagram, LinkedIn), and direct outreach. No software, API, or AI capabilities are disclosed; the technology base is conventional clinical operations supported by conventional marketing channels and centralized IRB capabilities. Revenue figures, funding history, and ownership structure beyond the AllerVie Health parent affiliation are not disclosed in available material.
AllerVie Clinical Research firmographics
Firmographics- Name
- AllerVie Clinical Research
- Legal name
- AllerVie Clinical Research
- Website
- https://allervieclinicalresearch.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- AllerVie Clinical Research is a U.S. clinical research site organization, founded in 1998 and affiliated with AllerVie Health, that conducts Phase II–IV clinical trials for pharmaceutical sponsors and CROs across 13+ allergy, asthma, and immunology indications through six clinic locations.
- Ownership category
- akta.pro rank
AllerVie Clinical Research industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Other Scientific and Technical Consulting Services (541690), Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
- akta.pro secondary industries
- Clinical CROs (Phase I–IV) (HLAGAAAA), Allergy & Immunology Clinics (HLAKAAAA)
Keywords
Where AllerVie Clinical Research is headquartered
LocationHeadquarters
- HQ city
- Not specified
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
AllerVie Clinical Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Clinical Trial Services: Revenue generated from conducting clinical trials for pharmaceutical sponsors and Contract Research Organizations (CROs). The company conducts Phase II, III, and IV trials and receives compensation for study execution, patient recruitment, and regulatory compliance services.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
AllerVie Clinical Research product offering
Product offeringCore offering
AllerVie Clinical Research conducts Phase II, III, and IV clinical trials for pharmaceutical companies and Contract Research Organizations (CROs), specializing in asthma, allergies, and immunology conditions across 48+ active studies at 6 nationwide clinic locations. The organization recruits patients through physician referrals and direct outreach, providing study-related care at no cost to participants while delivering qualified compliant study patients, regulatory documentation, and timely case report form completion to sponsors. As part of the AllerVie Health network, it leverages a national network of board-certified allergists and immunologists staffed by ACRP-certified research coordinators.
Product overview
AllerVie Clinical Research is a clinical research organization that operates as a unified platform conducting Phase II, III, and IV clinical trials. The company focuses on asthma, allergies, and immunology conditions through multiple study areas including Asthma, COPD, Eczema, Environmental Allergies, Food Allergies, GI, Hereditary Angioedema, Hives, Immunodeficiency, Nasal Studies, and Alopecia. AllerVie offers services to three primary segments: patients who may participate in clinical trials at no cost, referring physicians who partner with the organization, and pharmaceutical sponsors/CROs who contract for clinical research services. The company leverages its affiliation with the AllerVie Health network to provide access to a national network of board-certified allergists and immunologists.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trials Services
Companies that use AllerVie Clinical Research
Customer profileSegments3 records
Ideal customer profiles3 records
AllerVie Clinical Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AllerVie Clinical Research partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- Pharmaceutical CompaniescorePharmaceutical companies engage AllerVie to conduct Phase II, III, and IV clinical trials for new drug development in asthma, allergies, and related immunological conditions.
- Contract Research Organizations (CROs)coreCROs partner with AllerVie to conduct clinical trials, leveraging the company's network of board-certified specialists and high completion rates.
- AllerVie Health NetworkcoreAllerVie Clinical Research is part of the AllerVie Health network, providing access to a national network of board-certified allergists and immunologists for clinical research participation.
- Referring PhysicianscoreBoard-certified allergists and immunologists refer patients to participate in clinical research studies conducted by AllerVie.
Scale indicators4 records
Recent moves5 records
Expansion highlights8 records
AllerVie Clinical Research competitors and assessment
Company assessmentMarket position
Weaknesses5 records
Competitive moat4 records
Key risks1 record
Key highlights6 records
Customer concentration
AllerVie Clinical Research social profiles
Digital presenceAllerVie Clinical Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
AllerVie Clinical Research leadership team
Management profileNumber of profiles
AllerVie Clinical Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AllerVie Clinical Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AllerVie Clinical Research
What does AllerVie Clinical Research do?
AllerVie Clinical Research conducts Phase II, III, and IV clinical trials for pharmaceutical companies and Contract Research Organizations (CROs), specializing in asthma, allergies, and immunology conditions across 48+ active studies at 6 nationwide clinic locations. The organization recruits patients through physician referrals and direct outreach, providing study-related care at no cost to participants while delivering qualified compliant study patients, regulatory documentation, and timely case report form completion to sponsors. As part of the AllerVie Health network, it leverages a national network of board-certified allergists and immunologists staffed by ACRP-certified research coordinators.
Is AllerVie Clinical Research a public or private company?
AllerVie Clinical Research is a private company. It is classified as corporate owned and is currently operating.
When was AllerVie Clinical Research founded?
AllerVie Clinical Research was founded in 1998. It employs 11 to 50 people.
Where is AllerVie Clinical Research based?
AllerVie Clinical Research is headquartered in Not specified, United States, in the North America region.
How does AllerVie Clinical Research make money?
One revenue line is on record: clinical Trial Services.
Does AllerVie Clinical Research have an API?
No public API is recorded for AllerVie Clinical Research.
What industry is AllerVie Clinical Research in?
AllerVie Clinical Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease), with a secondary code of HLAGAAAA, Clinical CROs (Phase I–IV). Its NAICS code is 541690 and its SIC code is 8731.